Atai Life Sciences Total Long Term Liabilities 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Atai Life Sciences total long term liabilities from 2020 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Atai Life Sciences Total Long Term Liabilities 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Atai Life Sciences total long term liabilities from 2020 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$19.5B
Quest Diagnostics (DGX)	$18B
DaVita (DVA)	$12.9B
Encompass Health (EHC)	$10B
Chemed (CHE)	$8.2B
Elanco Animal Health (ELAN)	$6.6B
RadNet (RDNT)	$5.9B
Option Care Health (OPCH)	$3.7B
Amedisys (AMED)	$2.9B
LifeStance Health (LFST)	$2.8B
Astrana Health (ASTH)	$2.3B
Addus HomeCare (ADUS)	$2.2B
U.S Physical Therapy (USPH)	$1.4B
Aveanna Healthcare Holdings (AVAH)	$1.1B
Pennant (PNTG)	$1.1B
Daxor (DXR)	$43M
MEDIROM Healthcare Technologies (MRM)	$15M
Psychemedics (PMD)	$14M
ATI Physical Therapy (ATIP)	$8M
Ontrak (OTRK)	$8M
IMAC Holdings (BACK)	$1M